Fair Health Regional Tracker: Telehealth Use Has Decreased Nationally
April 2023 numbers include the privately insured, such as Medicare Advantage.
National telehealth use decreased 5.4% in April 2023, from 5.6% of medical claim lines in March to 5.3% in April, according to FAIR Health's Monthly Telehealth Regional Tracker. The decrease followed an increase in March 2023. In April, telehealth utilization also decreased in all four US census regions—the Midwest (4.7%), Northeast (6.3%), South (6.8%), and West (6.4%). The data represent the privately insured population, including Medicare Advantage and excluding Medicare Fee-for-Service and Medicaid.
Mental health conditions, the top-ranking telehealth diagnosis nationally and in every region, rose from 67.4% of telehealth claim lines nationally in March 2023 to 68.4% in April, marking the fourth straight month of national increases.
The percentage of telehealth claim lines for the second-place diagnosis, acute respiratory diseases and infections, decreased nationally in April, falling from 3.2% in March to 2.7% in April. This was the fourth consecutive national monthly decrease for this diagnosis.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Racial, Social, and Economic Factors Drive Resilience During COVID-19 Pandemic, Study Finds
July 18th 2025The study reveals that resilience varies significantly by race, education, income, and insurance status, highlighting the role of social determinants and systemic inequities in shaping health outcomes.
Thermo Fisher, Sanofi Expand Partnership to Boost Sterile Drug Production
July 16th 2025Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support production of Sanofi therapies and expand capacity for US-based pharma and biotech manufacturing.
